Nutrien (NYSE:NTR) Raised to Outperform at Raymond James

Nutrien (NYSE:NTR) was upgraded by equities researchers at Raymond James from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage presently has a $60.00 target price on the stock, up from their prior target price of $58.00. Raymond James’ target price would indicate a potential upside of 24.87% from the company’s previous close.

Several other research analysts also recently weighed in on the company. UBS Group downgraded Nutrien from a “buy” rating to a “neutral” rating and dropped their target price for the stock from $66.00 to $51.00 in a research note on Thursday, October 10th. Barclays dropped their target price on Nutrien from $68.00 to $55.00 and set an “overweight” rating on the stock in a research note on Friday, August 16th. Mizuho dropped their price target on Nutrien from $55.00 to $52.00 and set a “neutral” rating on the stock in a research note on Thursday, August 8th. BMO Capital Markets reduced their price target on shares of Nutrien from $80.00 to $75.00 and set an “outperform” rating for the company in a research report on Friday, August 9th. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $60.00 price target on shares of Nutrien in a research report on Friday, September 20th. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, Nutrien presently has an average rating of “Hold” and a consensus price target of $60.06.

Nutrien Trading Down 1.5 %

NTR opened at $48.05 on Tuesday. The firm has a market cap of $23.73 billion, a price-to-earnings ratio of 32.25, a PEG ratio of 1.68 and a beta of 0.80. The company has a current ratio of 1.27, a quick ratio of 0.82 and a debt-to-equity ratio of 0.38. Nutrien has a 12 month low of $44.65 and a 12 month high of $60.87. The stock has a fifty day moving average price of $47.98 and a 200-day moving average price of $49.57.

Nutrien (NYSE:NTR) last announced its earnings results on Wednesday, November 6th. The company reported $0.39 earnings per share for the quarter, missing the consensus estimate of $0.43 by ($0.04). Nutrien had a return on equity of 6.99% and a net margin of 2.79%. The business had revenue of $5.35 billion for the quarter, compared to analysts’ expectations of $5.26 billion. During the same quarter last year, the firm earned $0.35 earnings per share. The firm’s quarterly revenue was down 5.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Nutrien will post 3.56 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Central Pacific Bank Trust Division purchased a new stake in shares of Nutrien during the 3rd quarter valued at $28,000. Family Firm Inc. purchased a new stake in Nutrien during the 2nd quarter worth $32,000. Andra AP fonden purchased a new stake in Nutrien during the 2nd quarter worth $51,000. Oakworth Capital Inc. purchased a new stake in Nutrien during the 2nd quarter worth $52,000. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new stake in Nutrien during the 2nd quarter worth $52,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Company Profile

Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.